Advanced in Heart Attack

Cezary Kepka

42 Alpejska Street, 
Warsaw, MZ, PL 
Advanced in Heart Attack
42 Alpejska Street, 
Warsaw, MZ, PL 
OverviewLocationsClinical Research

Overview

Cezary Kepka practices in Warsaw, Poland. Kepka is rated as an Advanced expert by MediFind in the treatment of Heart Attack. Their top areas of expertise are Coronary Heart Disease, Atherosclerosis, Congenital Coronary Artery Malformation, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Their clinical research consists of co-authoring 146 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Heart Attack.

Locations

42 Alpejska Street, Warsaw, MZ 04628, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Procedure, Device
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Enrollment Status: Completed
Publish Date: September 17, 2019
View 1 Less Clinical Trial

146 Total Publications

Epicardial fat: a non-invasive, non-contrast imaging biomarker for high-risk plaque monitoring in computed tomography.
Epicardial fat: a non-invasive, non-contrast imaging biomarker for high-risk plaque monitoring in computed tomography.
Journal: Polish archives of internal medicine
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kepka's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile